Select to view the solutions available in your location.
Track orders, get results, manage personal information, and more.
Order tests, track orders, get results, and more.
Learn more about our innovative products and services that help detect cancer earlier and power smarter treatment decisions.
Exact Sciences is working to eradicate cancer by delivering a portfolio that gives providers the information they need to better serve their patients across the cancer care continuum — starting with familial risk.
Find out how our scientific rigor, quality standards, and development of future tests make us a leader in cancer testing and treatment guidance.
Exact Sciences expects the test to be available in 2025, pending approval.
Learn all about Exact Sciences, including our purpose, the people who drive it, our history, and the impact we’ve made.
The company’s commitment to community involvement keeps paying off when employees get back from giving back.
Explore stories, news, and events that highlight our innovation, technology, and people fighting cancer on all fronts.
Digital health publisher Everyday Health announced last week that Cologuard, the first and only FDA-approved noninvasive stool DNA screening test for colorectal cancer, is among the winners for the for the 2nd Annual Everyday Health Awards for Innovation.
The Everyday Health Awards for Innovation go to services and technologies that are "dedicated to improving overall health and wellbeing."
"These awards continue to bring the most inventive and creative digital health technologies and services to the forefront," said Everyday Health Executive Vice President and Chief Operating Officer Paul Slavin in a release "Each of the winners demonstrated an incredible understanding about where the digital health marketplace is going and how we can propel it forward."
For more information on the Everyday Health Award for Innovation, view the official news release.